{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T10:29:02Z","timestamp":1774434542274,"version":"3.50.1"},"reference-count":18,"publisher":"Wiley","issue":"10","license":[{"start":{"date-parts":[[2005,10,3]],"date-time":"2005-10-03T00:00:00Z","timestamp":1128297600000},"content-version":"vor","delay-in-days":2,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Int J Dermatology"],"published-print":{"date-parts":[[2005,10]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p><jats:bold>Background\u2002<\/jats:bold> Pemphigus, a common immunobullous disease of skin and mucous membranes affecting both sexes of all ages, was almost fatal before the advent of corticosteroids. Better strategies to avoid their side\u2010effects and recent introduction of adjuvant therapy has further improved its prognosis. As the treatment remains need\u2010based and patient\u2010specific, different regimens and strategies have evolved, each with its own merits and demerits.<\/jats:p><jats:p>This retrospective hospital\u2010based study was carried out to understand the clinico\u2010therapeutic aspects of pemphigus in our clinic.<\/jats:p><jats:p><jats:bold>Methods\u2002<\/jats:bold> Medical records of all new patients admitted to our hospital with the diagnosis of pemphigus from 1990 to 2002 were analyzed.<\/jats:p><jats:p>The diagnosis was mainly clinical and confirmed by positive Tzanck's test and histopathology. All patients were assessed clinically on a severity score of 1+\u00a0to 4+.<\/jats:p><jats:p>These patients had received treatment with dexamethasone\u2010cyclophosphamide pulse (DCP) therapy, oral mini\u2010pulse (OMP) with betamethasone, or intramuscular triamcinolone acetonide alone or with azathioprine, dapsone or cyclophosphamide. They were followed up for clinical remission and side\u2010effects of therapy.<\/jats:p><jats:p><jats:bold>Results\u2002<\/jats:bold> There were a total of 54 new patients comprising 53.7% females and 46.3% males, and 12.9% of these were &lt;\u00a018\u00a0years of age. Pemphigus vulgaris was the commonest clinical type seen in 81.48% and mucosal involvement was seen in 63.63% of cases. The severity of mucosal lesions was not proportionate to that of cutaneous lesions. Associated diseases seen were seropositive rheumatoid arthritis, hypertension, diabetes mellitus and hyperthyroidism in one case each.<\/jats:p><jats:p>Dexamethasone\u2010cyclophosphamide pulse therapy was given to 75% of the pemphigus vulgaris patients while those having less severe disease were treated with other regimens. In general, clinical remission was seen after 2\u201316 (mean 6.5) DCP doses. Two patients have been in complete remission for the last 5 and 7\u00a0years of completion of DCP therapy, respectively. Addition of other adjuvants to corticosteroids was also helpful. However, azathioprine 50\u00a0mg\/day was not as effective as cyclophosphamide 50\u00a0mg\/day. Menstrual irregularities, amenorrhoea, azoospermia, rise in blood pressure and glycosuria were the major side\u2010effects seen during DCP pulse therapy. Drop out rate was unacceptably high with all modes of treatment, although with DCP therapy it appears to be partly owing to early disease control. There was no mortality in this series.<\/jats:p><jats:p><jats:bold>Conclusions\u2002<\/jats:bold> Pemphigus vulgaris is the commonest clinical type. Mucosal surfaces other than the oral cavity are uncommonly involved, it may herald the onset of disease and takes longer to heal. Dexamethasone\u2010cyclophosphamide pulse therapy seems to have a definite advantage over treatment with steroids alone, especially in terms of better control of disease activity, near absence of steroid side\u2010effects and significantly reduced hospital stay. However, ways and means to reduce gonadal toxicity of adjuvants need to be explored as DCP therapy is likely to stay as a treatment of choice.<\/jats:p>","DOI":"10.1111\/j.1365-4632.2005.02218.x","type":"journal-article","created":{"date-parts":[[2005,10,3]],"date-time":"2005-10-03T08:22:55Z","timestamp":1128327775000},"page":"821-827","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":55,"title":["Twelve\u2010year clinico\u2010therapeutic experience in pemphigus: A retrospective study of 54 cases"],"prefix":"10.1111","volume":"44","author":[{"given":"Vikram K.","family":"Mahajan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nand Lal","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ramesh Chander","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Geeta","family":"Garg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2005,10,3]]},"reference":[{"key":"e_1_2_5_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0190-9622(99)70145-3"},{"key":"e_1_2_5_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0733-8635(05)70305-3"},{"key":"e_1_2_5_4_2","volume-title":"Pulse Therapy in Pemphigus and Other Diseases","author":"Pasricha JS","year":"2000"},{"key":"e_1_2_5_5_2","first-page":"534","volume-title":"Andrew's Diseases of the Skin","author":"Arnold HL","year":"1990"},{"key":"e_1_2_5_6_2","first-page":"1847","volume-title":"Textbook of Dermatology","author":"Pandhi RK","year":"1998"},{"key":"e_1_2_5_7_2","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1001\/archderm.1973.01620180083027","article-title":"Pemphigus vulgaris in 3\u00bd year\u2010old baby","volume":"107","author":"Berger BW","year":"1973","journal-title":"Arch Dermatol"},{"key":"e_1_2_5_8_2","doi-asserted-by":"publisher","DOI":"10.1159\/000250215"},{"key":"e_1_2_5_9_2","doi-asserted-by":"publisher","DOI":"10.1111\/1523-1747.ep12612836"},{"key":"e_1_2_5_10_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.1988.tb07104.x"},{"key":"e_1_2_5_11_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-4362.1990.tb04767.x"},{"key":"e_1_2_5_12_2","first-page":"143","article-title":"Dexamethasone\u2010cyclophosphamide pulse therapy in bullous autoimmune dermatoses","volume":"44","author":"Appelhans M","year":"1993","journal-title":"Hautarzt"},{"key":"e_1_2_5_13_2","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.1001\/archderm.1996.03890360112026","article-title":"Curative treatment for pemphigus","volume":"132","author":"Pasricha JS","year":"1996","journal-title":"Arch Dermatol"},{"key":"e_1_2_5_14_2","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1001\/archderm.1996.03890360021005","article-title":"Treatment of pemphigus vulgaris with brief high\u2010dose intravenous glucocorticoids","volume":"132","author":"Werth VP","year":"1996","journal-title":"Arch Dermatol"},{"key":"e_1_2_5_15_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-4362.1990.tb04765.x"},{"key":"e_1_2_5_16_2","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.1996.03890260105016"},{"key":"e_1_2_5_17_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0190-9622(87)70226-6"},{"key":"e_1_2_5_18_2","doi-asserted-by":"crossref","first-page":"2110","DOI":"10.1001\/jama.1993.03500160080036","article-title":"Side effects of glucocorticoid treatment: experience of the optic neuritis treatment trial","volume":"269","author":"Chrousos GA","year":"1993","journal-title":"JAMA"},{"key":"e_1_2_5_19_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-93-1-109"}],"container-title":["International Journal of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-4632.2005.02218.x","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-4632.2005.02218.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1365-4632.2005.02218.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,9]],"date-time":"2023-10-09T16:53:11Z","timestamp":1696870391000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-4632.2005.02218.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,10]]},"references-count":18,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2005,10]]}},"alternative-id":["10.1111\/j.1365-4632.2005.02218.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1365-4632.2005.02218.x","archive":["Portico"],"relation":{},"ISSN":["0011-9059","1365-4632"],"issn-type":[{"value":"0011-9059","type":"print"},{"value":"1365-4632","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,10]]},"assertion":[{"value":"2005-10-03","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}